Christopher K. Scott - Dec 4, 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
COO, CFO & Secretary
Signature
/s/ Christopher K. Scott
Stock symbol
IRMD
Transactions as of
Dec 4, 2021
Transactions value $
-$51,604
Form type
4
Date filed
12/8/2021, 03:18 PM
Previous filing
Nov 24, 2021
Next filing
Dec 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +2.95K +10.32% 31.5K Dec 4, 2021 Direct F1
transaction IRMD Common Stock Tax liability -$51.6K -1.16K -3.68% $44.41 30.4K Dec 4, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -2.95K -100% $0.00* 0 Dec 4, 2021 Common Stock 2.95K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.